SB 825 Modifies provisions relating to limitations on prescribing opioids
Sponsor: Sater
LR Number: 5577S.01I Fiscal Notes
Committee: Seniors, Families and Children
Last Action: 2/7/2018 - SCS Voted Do Pass S Seniors, Families and Children Committee (5577S.03C) Journal Page:
Title: Calendar Position:
Effective Date: August 28, 2018

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2018 Senate Bills

Current Bill Summary

SCS/SB 825 - This act limits certain initial prescriptions of opioid controlled substances to no more than a 7-day supply for the treatment of acute pain. Prior to prescribing the opioid, a practitioner shall consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, as well as inform the patient of the risks associated with the prescribed opioid. If, in the practitioner's medical judgment, more than a 7-day supply is required to treat the patient, the practitioner may issue a prescription for the quantity needed after noting in the patient's medical record the condition triggering the necessity for a greater quantity and that a nonopioid was not appropriate. The provisions of this act shall not apply to prescriptions for a patient who is currently undergoing treatment for cancer, is receiving hospice care or palliative care, is a resident of a long-term care facility, or is receiving treatment for substance abuse or opioid dependence.

This act is substantially similar to provisions in the truly agreed to and finally passed CCS/HCS/SS/SCS/SB 826 (2018), SCS/HCS/HB 2105 (2018), SCS/HCS/HB 1618 (2018), and HCB 15 (2018).